bpc 157 systemic or local BPC-157 and the Difference Between an Evidence Gap and a Cover-Up: What the entire human evidence base actually looks like, and the questions to ask next. — WellFounded BPC-157 Peptide: Benefits for Healing,

well-documented combination Table 2 Practical comparison for GH-axis peptide selection

Keep track of which vial you are drawing from, especially if you have multiple peptides in your research program

Human clinical trials are limited, and optimal dosing, long-term safety, and comparative effectiveness with other therapies remain unclear

You get receptor competition that may actually reduce overall effectiveness

Injectable use is often marketed as more direct, but neither route has enough high-quality clinical evidence to support routine use for tendonitis

At 10mg/mL (10mg vial + 1mL water), a 4mg dose requires 40 units